United States - English - NLM (National Library of Medicine)

kentucky performance products - dihydroxyaluminum sodium carbonate (unii: 84h8z9550j) (carbonate ion - unii:7ujq5ope7d) - endura-max plus™ oral electrolytes for endurance horses endura-max plus is an electrolyte supplement designed specifically for endurance horses. contains key electrolytes relinguished in sweat, including sodium, chloride and potassium.  unlike other electrolytes, endura-max plus also provides calcium and magnesium. ingredients: salt (sodium chloride), potassium chloride, starch, calcium acetate, calcium carbonate, dihydroxyaluminum sodium carbonate, magnesium oxide, natural flavors.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - pravastatin sodium 10mg;   - tablet - 10 mg - active: pravastatin sodium 10mg   excipient: dihydroxyaluminium sodium carbonate iron oxide red lactose monohydrate sodium stearyl fumarate - latest regulatory activity

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - pravastatin sodium 20mg;   - tablet - 20 mg - active: pravastatin sodium 20mg   excipient: dihydroxyaluminium sodium carbonate iron oxide yellow lactose monohydrate sodium stearyl fumarate - latest regulatory activity

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - pravastatin sodium 40mg;   - tablet - 40 mg - active: pravastatin sodium 40mg   excipient: dihydroxyaluminium sodium carbonate iron oxide red lactose monohydrate sodium stearyl fumarate - latest regulatory activity

United States - English - NLM (National Library of Medicine)

primary pharmaceuticals, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals ( see warnings; gastrointestinal bleeding, ulceration, and perforation ). diclofenac is indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis diclofenac sodium delayed-release tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product ( see warnings; anaphylactic reactions, serious skin reactions ). - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsa

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

batterjee pharmacetical factory - dihydroxyaluminium sodium carbonate - chewable tablet - 320 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

batterjee pharmacetical factory, saudi arabia - dihydroxyaluminium sodium carbonate,simethicone - chewable tablet - 320,20 mg,

Israel - English - Ministry of Health

cts ltd - diclofenac sodium - patches - diclofenac sodium 140 mg/patch - diclofenac - diclofenac - dicloplast is indicated for topical treatment of rheumatic diseases, pain and non-infectious inflammation.

Israel - English - Ministry of Health

cts ltd - diclofenac sodium - patches - diclofenac sodium 140 mg - diclofenac - diclofenac - dicloplast is indicated for topical treatment of rheumatic diseases, pain and non-infectious inflammation.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

nichi-iko pharmaceutical co.,ltd - aspirin; magnesium carbonate; dihydroxyaluminum aminoacetate - pale orange tablet, diameter: 8.0 mm, thickness: 3.6 mm